Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity - GBI Research Reports

Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity

Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity - GBI Research Reports
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
Published Jul 10, 2012
105 pages — Published Jul 10, 2012
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs report, Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity provides detailed insight into the Europe API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and CMO growth in the region and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Europe API market, covering all the major parameters.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Europe is the third largest regional market for APIs by revenue in the world. European active pharmaceutical ingredients (API) market revenue held a share of around 24.2% of global API market revenue of 108.6 $ billion in 2011. Total revenue generated by the European API market was $26,288.96 million in 2011 and is expected to grow at a CAGR of 6.5% to reach $38,255.67 million by 2017.This will be supported by healthy demand from generic and biotech API sectors.

Scope

- Market revenue data for APIs from 2005 to 2011 and forecast for six years to 2017.
- API markets in key countries in the region: Germany, France, Italy, the Uk, Spain
- API industry structure and market trends such as a shift in manufacturing and growth in biotechnology for the Europe region.
- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and government initiatives like price reimbursement cut.
- Detailed historical, forecast trend and share analysis of API revenue based on product types (Synthetic and Biotech APIs) in the Europe market and in key countries of the region.
- Detailed historical, forecast trend and share analysis of API revenue based on customer base (Generic and Innovative for Synthetic APIs) (Biosimilars and biologics for Biotech Apis) in the Europe market and in key countries of the region.
- Analysis of API revenue based on therapeutic categories in the Europe and key countries.

Reasons to buy

- Develop business strategies with the help of specific insights on the Europe API market.
- Identify opportunities and challenges in the Europe API market.
- Invest in the growing segments of the API market.
- Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Europe API market.
- Benchmark your operations and strategies against the major players in the global API market.

Keywords

API,Generic API, Branded API,Biotech, generic, innovator drug, therapeutic, Biologics, Biosimilars

  
Source:
Document ID
GBICH0070MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents65
  List of Tables81
  List of Figures92
Introduction111
Contract Manufacturing Organizations (CMO) an Upcoming Trend in Europe API Manufacturing125
  Introduction121
    How Does Outsourcing to CMOs Take Place?121
  Europe CMO Market Drivers131
    Availability of Low-Cost Skilled Manpower131
    Key Benefits of API Manufacturing Outsourcing in Europe141
  The Eastern European CMO Market152
Europe Active Pharmaceutical Ingredients Market1730
  Market Overview171
  API Classification171
    API Classification Based on Synthesis Routes181
      Synthetic API181
      Biotech API181
    Types based on Customer Base181
  Industry Structure191
  Europe API Market Drivers201
    Increased CMO Opportunities is Expected to Improve the Production of Generics and Fuel the Revenues of API in the Region201
    Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population are Driving the Growth of the European API Market201
    Attractiveness towards Biopharmaceutical Therapies Supports the Growth of the API Market in Europe201
    European Regulatory Framework Facilitating Development of Biosimilars201
    Differences in VAT rates on Pharma Products is Expected to Increase Parallel Trade in Europe201
  Europe API Market Restraints211
    Increased Consumption of Generics211
    Increasing Patent Expiries Hamper the Growth of the European API Market211
    Price Cuts Restrict the Revenue Growth of the European API Market213
  Europe API Total Revenue Analysis242
  Europe Revenue Share by Product Types261
  Europe Synthetic API Market Analysis271
    Europe Synthetic API Market Drivers271
      Healthy Growth in Generic Sectors Drives the Overall Growth of the Synthetic API Market in Europe271
      Growth in Central and Eastern European Countries to Boost the Growth of the Synthetic API Market271
    Europe Synthetic API Market Restraints271
      A Slowdown in the Growth of the Innovative Sector in Matured Markets will Restrict the Growth of the Synthetic API Market271
      High Competitiveness due to Fragmented API Market is a Significant Restraint for the Growth of the European Synthetic API Market271
    Europe Synthetic API Total Synthetic Revenue Analysis 2005-2017282
      Europe Synthetic API Revenue Share Analysis by Countries 2011302
      Europe Synthetic API Revenue Share Trend Analysis by Countries321
    European Synthetic API Market Revenue Share Analysis Based on Customer Base in 2011331
    Europe Synthetic API Revenue Trend Analysis 2005-2017342
  Europe Biotech API Market Analysis361
    Europe Biotech API Market Drivers361
      Increasing Uptake of Biopharmaceuticals or Specialty Drugs across Different Therapeutic Areas361
      Increasing Biologics Clusters361
    Europe Biotech API Market Restraints361
      The Complex Manufacturing Procedures for Biotech API is expected to Decrease the Frequency of New Entrants in to the Market361
      Complex Cost Structures in Outsourcing Biotech API Manufacturing Process361
    Europe Biotech API Revenue Analysis 2005-2017371
      Europe Biotech API Revenue Share Analysis by Countries 2011382
      Europe Biotech API Revenue Share Trend Analysis by Countries 2011401
  Europe Biotech API Market Revenue Analysis by Customer Base411
    Europe Biotech API Market Revenue Share Analysis by Customer Base411
  Europe Patent Expiry of Leading Biologics423
  Europe API Revenue Split Up by Therapeutic Applications452
Germany Active Pharmaceutical Ingredients Market4711
  Germany API Market Overview471
  Germany Total API Revenue Analysis based on the synthesis routes 2005-2017472
  Germany API Revenue Share Analysis by Product Types 2005-2017491
  Germany API Revenue Analysis based on Customer Base501
    Germany Synthetic API Revenue Analysis by Customer Base, 2005-2017502
    Germany Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017521
    Germany Biotech API Revenue Analysis by Customer Base, 2005-2017532
    Germany Biotech API Revenue Share Analysis by Customer Base, 2005-2017551
  Germany API Revenue share Analysis by Therapeutic Applications562
France Active Pharmaceutical Ingredients Market5811
  France API Market Overview581
  France Total API Revenue Analysis Based on Synthesis Routes 2005-2017582
  France API Revenue Share Analysis by Product Types 2005-2017601
  France API Revenue Analysis based on Customer Base611
    France Synthetic API Revenue Analysis by Customer Base, 2005-2017612
    France Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017631
    France Biotech API Revenue Analysis by Customer Base, 2005-2017642
    France Biotech API Revenue Share Analysis by Customer Base, 2005-2017661
  France API Revenue share Analysis by Therapeutic Applications672
Italy Active Pharmaceutical Ingredients Market6911
  Italy API Market Overview691
  Italy Total API Revenue Analysis based on Synthesis Routes 2005-2017692
  Italy API Revenue Share Analysis by Product Types 2005-2017711
  Italy API Revenue Analysis based on Customer Base721
    Italy Synthetic API Revenue Analysis by Customer Base, 2005-2017722
    Italy Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017741
    Italy Biotech API Revenue Analysis by Customer Base, 2005-2017752
    Italy Biotech API Revenue Share Analysis by Customer Base, 2005-2017771
  Italy API Revenue share Analysis by Therapeutic Applications782
The UK Active Pharmaceutical Ingredients Market8011
  The UK API Market Overview801
  The UK Total API Revenue Analysis based on Synthesis Routes 2005-2017802
  The UK API Revenue Share Analysis by Product Types 2005-2017821
  The UK API Revenue Analysis based on Customer Base831
    The UK Synthetic API Revenue Analysis by Customer Base, 2005-2017832
    The UK Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017851
    The UK Biotech API Revenue Analysis by Customer Base, 2005-2017862
    The UK Biotech API Revenue Share Analysis by Customer Base, 2005-2017881
  The UK API Revenue share Analysis by Therapeutic Applications892
Spain Active Pharmaceutical Ingredients Market9111
  Spain API Market Overview911
  Spain Total API Revenue Analysis based on Synthesis Routes 2005-2017912
  Spain API Revenue Share Analysis by Product Types 2005-2017931
  Spain API Revenue Analysis based on Customer Base941
    Spain Synthetic API Revenue Analysis by Customer Base, 2005-2017942
    Spain Synthetic API Market Revenue Share Analysis by Customer Base, 2005-2017961
    Spain Biotech API Revenue Analysis by Customer Base, 2005-2017972
    Spain Biotech API Revenue Share Analysis by Customer Base, 2005-2017991
  Spain API Revenue share Analysis by Therapeutic Applications1002
Appendix1024
  Abbreviations1021
  Market Definitions1021
  References1021
  Methodology1032
    Coverage1031
    Secondary Research1041
    Primary Research1041
    Expert Panel Validation1041
  Contact Us1041
  Disclaimer1051

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity" Jul 10, 2012. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-API-Market-in-Europe-to-2017-Pricing-and-Reimbursement-Initiatives-Supporting-Generic-Drug-Growth-with-CMOs-Expected-to-Account-for-Majority-of-the-Manufacturing-Activity-2115-452>
  
APA:
GBI Research Reports. (2012). Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity Jul 10, 2012. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-API-Market-in-Europe-to-2017-Pricing-and-Reimbursement-Initiatives-Supporting-Generic-Drug-Growth-with-CMOs-Expected-to-Account-for-Majority-of-the-Manufacturing-Activity-2115-452>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.